Studies on the antitumor activity of an alazopeptin isolated from a new strain of Streptomyces.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D001412:Bacillus subtilis / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004151:Dipeptides; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009646:Norleucine / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D010455:Peptides / Q000032:analysis* / Q000494:pharmacology / Q000627:therapeutic use; D013302:Streptomyces / Q000032:analysis*
D000903:Antibiotics, Antineoplastic; D004151:Dipeptides; D010455:Peptides; D009646:Norleucine; C006439:allyl-(6-diazo-5-oxo)-norleucyl-(6-diazo-5-oxo)-norleucine